Sorrento Therapeutics (SRNE) Earnings
|
Expand Research on SRNE
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -49.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -10.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/9/23 | Q422 | N/A | -$0.20 | N/A | N/A | $17.28M | N/A | N/A | N/A | ||
| 11/8/22 | Q322 | -$0.40 | -$0.28 | -$0.12 | $12.06M | $19.13M | N/A | ![]() | ![]() | Details | |
| 11/8/22 | Q322 | -$0.40 | -$0.25 | -$0.15 | $12.06M | $11.69M | N/A | ![]() | ![]() | Details | |
| 8/15/22 | Q322 | -$0.37 | -$0.25 | -$0.12 | $8.37M | $18.75M | N/A | ![]() | ![]() | Details | |
| 8/15/22 | Q222 | -$0.37 | -$0.25 | -$0.12 | $8.37M | $18.75M | N/A | ![]() | ![]() | Details | |
| 8/15/22 | Q222 | -$0.37 | -$0.25 | -$0.12 | $8.37M | $18.75M | N/A | ![]() | ![]() | Details | |
| 8/15/22 | Q222 | -$0.37 | -$0.25 | -$0.12 | $8.37M | $18.75M | N/A | ![]() | ![]() | Details | |
| 11/16/15 | Q315 | -$0.03 | N/A | N/A | $1.1M | $1.28M | N/A | ![]() | ![]() | Details |


